Zandy Forbes, Ph.D., is the President & CEO of Meira GTx, blending her expertise in molecular genetics and healthcare investing. She shares insights on risk mitigation in biotech, drawing from her dynamic transition from investment banking to leading a gene therapy company. Forbes discusses the challenges of managing personal fears while navigating investment decisions, the significance of strategic planning, and her company’s advancements in innovative treatments for conditions like blindness. Her unique experiences blend science and finance in the high-stakes biotech landscape.

Zandy Forbes, founder and CEO of MeiraGTx, discusses the evolution of gene therapy, manufacturing advancements, and the challenges and opportunities in the biotech sector. She highlights Meira's innovative approach to genetic medicines for non-inherited diseases, emphasizing strategies to navigate the complex landscape of biotech. The podcast explores controlling genes through oral pill dosing, optimizing capital efficiency, and diversifying disease areas with a technology-focused approach.